SeaStar Medical Holding: SCD Device Earns FDA Breakthrough Designation for Hepatorenal Syndrome, Shares Soar
SeaStar Medical Holding Corporation (Nasdaq: ICU) has achieved a significant milestone in the development of its revolutionary medical device. Focused on pioneering solutions to mitigate
